Cargando…

Role of Re-Resection in Non–Muscle-Invasive Bladder Cancer

Restaging, or second transurethral resection (TUR), is essential to successful management of high-risk, non–muscle-invasive bladder cancer. Here we review the relevant literature documenting the role of restaging TUR. Cohort and randomized studies show that restaging TUR detects more tumors than ini...

Descripción completa

Detalles Bibliográficos
Autor principal:	Herr, Harry W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	TheScientificWorldJOURNAL 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720095/ https://www.ncbi.nlm.nih.gov/pubmed/21298219 http://dx.doi.org/10.1100/tsw.2011.29

Ejemplares similares

Is ‘second-look’ (re-staging) transurethral resection of bladder tumours a new standard of care?
por: Herr, Harry, et al.
Publicado: (2011)

The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer
por: Russell, Christopher M., et al.
Publicado: (2016)

Current and Innovative Approaches in the Treatment of Non-muscle Invasive Bladder Cancer: The Role of Transurethral Resection of Bladder Tumor and Organoids
por: Taskovska, Milena, et al.
Publicado: (2020)

The impact of early re-resection in patients with pT1 high-grade non-muscle invasive bladder cancer
por: Vasdev, Nikhil, et al.
Publicado: (2012)

A Systematic Review on the Role of Repeat Transurethral Resection after Initial en Bloc Resection for Non-Muscle Invasive Bladder Cancer
por: Hu, Henglong, et al.
Publicado: (2022)

The current role of circulating biomarkers in non-muscle invasive bladder cancer
por: Rink, Michael, et al.
Publicado: (2019)

Predictors of Outcome of Non–Muscle-Invasive and Muscle-Invasive Bladder Cancer
por: Youssef, Ramy F., et al.
Publicado: (2011)

Prediction tools in non-muscle invasive bladder cancer
por: Zamboni, Stefania, et al.
Publicado: (2019)

Multivariate Analysis of the Prognostic Significance of Resection Weight after Transurethral Resection of Bladder Tumor for Non-Muscle-Invasive Bladder Cancer
por: Kwon, Dae Hyeon, et al.
Publicado: (2012)

Non-muscle invasive bladder cancer risk stratification
por: Isharwal, Sumit, et al.
Publicado: (2015)

Intravesical chemotherapy in non-muscle-invasive bladder cancer
por: Porten, Sima P., et al.
Publicado: (2015)

Histological variants in non-muscle invasive bladder cancer
por: Baumeister, Philipp, et al.
Publicado: (2019)

Active surveillance for non-muscle invasive bladder cancer
por: Marcq, Gautier, et al.
Publicado: (2019)

An evaluation to define the role of repeat transurethral resection in a treatment algorithm for non-muscle-invasive bladder cancer
por: Fujikawa, Atsushi, et al.
Publicado: (2012)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

Surveillance and Treatment of Non-Muscle-Invasive Bladder Cancer in the USA
por: Barocas, Daniel A., et al.
Publicado: (2012)

Guideline-based management of non-muscle invasive bladder cancer
por: Gregg, Justin R., et al.
Publicado: (2015)

Review on gender differences in non-muscle invasive bladder cancer
por: Bilski, Konrad, et al.
Publicado: (2019)

Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
por: Zhu, Huier, et al.
Publicado: (2019)

Prostatic urethra recurrence after transurethral resection of bladder tumor (TURBT) for non‐muscle‐invasive bladder cancer (NMIBC)
por: Bilim, Vladimir, et al.
Publicado: (2022)

Role of PET/CT in muscle-invasive bladder cancer
por: Kim, Seok-ki
Publicado: (2020)

Role of immunotherapy in Bacillus Calmette-Guérin unresponsive: non-muscle invasive bladder cancer
por: Suh, Jungyo, et al.
Publicado: (2020)

The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder Cancer
por: Douglass, Laura, et al.
Publicado: (2016)

Predictive factors for residual tumor and tumor upstaging on relook transurethral resection of bladder tumor in non-muscle invasive bladder cancer
por: Gill, Tejpal S., et al.
Publicado: (2014)

Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer
por: Chhaya, Saachi, et al.
Publicado: (2023)

Device-assisted intravesical therapy for non-muscle invasive bladder cancer
por: Hendricksen, Kees
Publicado: (2019)

Neoadjuvant versus Adjuvant Chemotherapy in Patients with Resectable Muscle-Invasive Bladder Cancer
por: Sawasdee, Anupong, et al.
Publicado: (2022)

Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease?
por: Klaile, Yvonne, et al.
Publicado: (2016)

Spinal anesthesia is associated with lower recurrence rates after resection of non-muscle invasive bladder cancer
por: Kweon, Tae Dong, et al.
Publicado: (2018)

Recurrence of Subepithelial Non-Muscle Invasive Bladder Cancer Following Transurethral Resection: A Case Report
Publicado: (2021)

Rotatable Bi-Channel En Bloc Resection of Bladder Tumor for Non-Muscle-Invasive Bladder Cancer in an Ex Vivo Porcine Model
por: Yao, Qiu, et al.
Publicado: (2023)

Neoadjuvant Immunotherapy for Muscle-Invasive Bladder Cancer
por: Peyrottes, Arthur, et al.
Publicado: (2021)

The Direct Anti-Cancer Effect of a Single Instillation of Epirubicin after Transurethral Resection of Bladder Tumor for Non-Muscle-Invasive Bladder Cancer
por: Shin, Yu Seob, et al.
Publicado: (2012)

Quality improvement in managing patients with non-muscle-invasive bladder cancer by introducing a surgical checklist for transurethral resection of bladder tumor
por: Kikuchi, Hiroshi, et al.
Publicado: (2022)

Non-Muscular Invasive Bladder Cancer: Re-envisioning Therapeutic Journey from Traditional to Regenerative Interventions
por: Shih, Kuan-Wei, et al.
Publicado: (2021)

Non-Muscle Invasive Bladder Cancer: A Review of the Current Trend in Africa
por: Cassell, Ayun, et al.
Publicado: (2019)

Should continuous bladder irrigation be recommended when single instillation of intravesical chemotherapy cannot be used after transurethral resection in low-risk non-muscle invasive bladder cancer?
por: Chemi, Joaquin, et al.
Publicado: (2023)

Thulium Laser Resection of Bladder Tumors vs. Conventional Transurethral Resection of Bladder Tumors for Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer Followed by Intravesical BCG Immunotherapy
por: Liu, Zheng, et al.
Publicado: (2021)

Transurethral en bloc resection with monopolar current for non-muscle invasive bladder cancer based on TNM system
por: Yang, Yongjun, et al.
Publicado: (2020)

Perioperative therapy in muscle invasive bladder cancer
por: Chatterjee, Ambarish, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ui5dvt4cadrh4p3a0djopkd62l